February 23, 2011
Researchers from the University of California, San Francisco, and Johns Hopkins University are recruiting patients to examine whether a drug prescribed to treat alcohol and cocaine addiction can reduce the amount of latent HIV among HIV-positive patients already taking combination therapy, Bloomberg reports. "The researchers plan to add [the drug] Antabuse to the patients' regular cocktail of AIDS drugs for two weeks, then check their blood after 24 weeks to see whether it has depleted the amount of latent HIV," according to the news service. The trial is expected to conclude in June 2012, according to ClinicalTrials.gov (Bennett, 2/22).
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.